Device for reshaping the heart in heart failure
Part of Heart & circulation clinical trials.
This study tests a device called Vsling™, which is placed inside the heart to help it pump better in people with heart failure. The device aims to reshape the heart's main pumping chamber, which may improve your symptoms and quality of life.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 85 years old.
- You have heart failure with a weakened heart pump, but your ejection fraction (a measure of pumping strength) is between 20% and 40%.
- Your heart's main pumping chamber (left ventricle) is enlarged, and the distance between certain heart muscles is increased.
- You have only mild or no leakage of your mitral valve (a heart valve) — not moderate or severe.
- You have symptoms like shortness of breath or fatigue that limit your daily activities (NYHA class II to IVa).
- You have not had recent heart procedures, dangerous heart rhythms, or a stroke, and you don't have severe kidney disease.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a new device called Vsling, which is placed inside the heart to help reshape the main pumping chamber (left ventricle) in people with heart failure. It may improve your heart's strength and reduce symptoms like shortness of breath.
This trial tests a less invasive procedure to reshape the heart in people with heart failure due to a scar or aneurysm. It aims to improve heart function and symptoms.
This trial tests a small device placed in the heart to help reduce fluid buildup and ease breathing in people with advanced heart failure. It might help you feel better and avoid hospital stays.
This trial tests a new device that is placed using a thin tube through a vein in the leg to repair a leaky mitral valve in people with heart failure. The goal is to see if it can reduce symptoms and improve quality of life beyond what usual medications can do.
This study tests a new device called the Vesalius TMVr system to fix a leaky mitral valve without open-heart surgery. It's for people with severe mitral regurgitation who are not good candidates for surgery.
This study tests a device called the Ventura IASD, which is implanted in the heart to relieve pressure and help with advanced heart failure symptoms. It is for people who are already scheduled to get this device and who have moderate symptoms despite taking heart medications.
Hear when a new HFrEF - Heart Failure with Reduced Ejection Fraction trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.